Cutaneous Squamous Cell Carcinoma
Treatment Recommendations among Radiation Oncologists in the Treatment of Cutaneous Squamous Cell Carcinoma with Perineural Invasion
12
Prognostic factors for metastatic cutaneous squamous cell carcinoma of the parotid
8
Reconstruction of a dorsal thoracic wall defect with a dorsal intercostal artery perforator flap after removal of a bulky cutaneous squamous cell carcinoma: a case report
6
Celecoxib suppresses cutaneous squamous-cell carcinoma cell migration via inhibition of SDF1-induced endocytosis of CXCR4
9
Original Article MicroRNA26 increases sensitivity of cutaneous squamous cell carcinoma to dacarbazine
7
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma
10
Organotypic in vitro models of human cutaneous squamous cell carcinoma
175
Exploring betapapillomavirus infections and their association with cutaneous squamous-cell carcinoma
143
Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma
19
A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes
14
Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
6
Identification of mTOR inhibitor-resistant genes in cutaneous squamous cell carcinoma
11
Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22 cases retrospective analysis
8
<p>MicroRNA-766 Promotes The Proliferation, Migration And Invasion, And Inhibits The Apoptosis Of Cutaneous Squamous Cell Carcinoma Cells By Targeting PDCD5</p>
12
CD109 and squamous cell carcinoma
8
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
5
The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK
9
Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases
12
Cutaneous squamous carcinoma in a patient with diabetic foot: an unusual evolution of a frequent complication
5
New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota
13